(OTCMKTS:EAPH) Looks Ahead to a Busy Month
By Jermaine Farmer - Orical report
FacebookTwitter
Easton Pharmaceuticals Inc (OTCMKTS:EAPH) is a micro-ca biopharma player that has increasingly captured the attention of the OTC trading crowd. Based on a little digging into recent press releases, it’s clear there are some important announcements on the way, including a couple potential key acquisitions. In addition, the company just announced after having received initial payment towards product purchase order from pharmaceutical multi-national Gedeon Richter’s Plc subsidiary – Gedeon Richter Mexico S.A.P.I. de C.V., the first shipment of “Gynofit” bacterial vaginosis treatment has been shipped and received in Mexico in preparation of its product launch in Puerto Vallarta, Mexico for February 16th.
According to the company’s recent release, Gedeon Richter will be showcasing the products as it launches its marketing and sales program with a steadily increasing marketing budget over the next 3 years. Easton / BMV will provide sales figures and projections sometime in the next quarter.
Easton Pharmaceuticals Inc (OTCMKTS:EAPH) frames itself as a specialty pharmaceutical company, designs, develops, and markets various topically-delivered drugs and therapeutic health care products.
Its products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women; and female sexual arousal disorder drug.
The company is also developing XILIVE, an early stage cancer drug. In addition, it is involved in the medical marijuana business. The company was formerly known as LAM Industries, Inc. and changed its name to Easton Pharmaceuticals Inc. in March 2010. Easton Pharmaceuticals Inc. was founded in 1997 and is based in Toronto, Canada.
According to company materials, “Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing medical device and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton has partnered with BMV Medica and together, own the exclusive distribution rights in Mexico and Latin America for patented women’s diagnostic and preventative care products, along with two generic cancer drugs Paclitaxel and Docetaxel.”
Find out when $EAPH stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
big.chart (579×335)
As the company communicates, “Gynofit” is a natural product treatment for women diagnosed with BV (Bacterial Vaginosis), a condition that affects nearly all women at some point in their lives and is one of the most common reasons for gynecological visits by women. In addition, Gynofit will be promoted for help in maintenance of a healthy vaginal flora. As previously announced, the agreement with Gedeon Richter Mexico S.A.P.I de C.V. provides for annual minimums in return for granting exclusivity. Gedeon Richter Plc and Gedeon Richter Mexico S.A.P.I. de C.V. has committed to a strong marketing plan for Gynofit and its success, which Easton / BMV and Gedeon Richter believe will steadily drive sales in Mexico over the next three years and beyond.
According to the company’s recent release, management notes that they continue to move forward with due diligence for the acquisition of revenue generating iBliss Inc., as previously announced, and expect to have the transaction completed sometime in the month of February once all terms of the agreement have been agreed to and finalized.
Traders take note: that’s a relatively blatant statement about an upcoming catalyst.
In fact, it gets better: the company goes on to state that “Easton is also confirming that it has entered into negotiations towards acquiring a second revenue generating company possessing strong international sales which could coincide with the closing of iBliss and BMV Medica S.A. Easton is also in late stage negotiations towards 2 (two) agreements with two 2 (two) medical marijuana companies, one in Jamaica and the other in the US, both expecting to potentially add significant and near term sales to Easton. Updates are expected this month or as they materialize.”
Recent action has seen 55% during the past month in terms of shareholder gains in the company. In addition, the listing has seen interest climb, with an increase in recent trading volume of exceeding 210% over the long run average. Since we last covered the name, the stock has moved 31% higher.
Currently trading at a market capitalization of $40.1M, EAPH has virtually no cash on the books, which is balanced by about $115K in total current liabilities. One should also note that debt has been growing over recent quarters. The company is pre-revenue at this point. As more color becomes clear on the name, we will review the situation and update our take. For continuing coverage on shares of $EAPH stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!
Sign Up for our 100% FREE Oracle Dispatch Newsletter
Submit
TAGSBIOPHARMAEAPHPHARMACEUTICALSTOPICALLY
FacebookTwitter
Previous article
A Closer Look at Eco Science Solutions Inc (OTCMKTS:ESSI)
Next article
New Partnership Potential Stirs Earth Science Tech Inc (OTCMKTS:ETST)
RELATED ARTICLESMORE FROM AUTHOR
ERBB stock
American Green Inc (OTCMKTS:ERBB) Garners Attention with New App
BNTC
Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC) Moving After Key Update
Silvercorp Metals
Silvercorp Metals Inc (OTCMKTS:SVMLF) Delivers the Goods
LEAVE A REPLY
POPULAR POSTS
NAKD Stock
Naked Brand Group Inc (NASDAQ:NAKD) Launches in Reaction to Product Launch
February 6, 2017
ERBB stock
American Green Inc (OTCMKTS:ERBB) Garners Attention with New App
February 6, 2017
NEWC stock
New Colombia Resources Inc (OTCMKTS:NEWC) Planting the Seeds
February 6, 2017
BNTC
Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC) Moving After Key Update
February 6, 2017
AZFL
AMAZONAS FLORESTAL COM USD0.001 (OTCMKTS:AZFL) Getting on Track
February 6, 2017
Silvercorp Metals
Silvercorp Metals Inc (OTCMKTS:SVMLF) Delivers the Goods
February 5, 2017
ETST
New Partnership Potential Stirs Earth Science Tech Inc (OTCMKTS:ETST)
February 5, 2017
Easton Pharmaceuticals Inc
Easton Pharmaceuticals Inc (OTCMKTS:EAPH) Looks Ahead to a Busy Month
February 5, 2017
Eco Science
A Closer Look at Eco Science Solutions Inc (OTCMKTS:ESSI)
February 5, 2017
CIIX stock
ChineseInvestors.com Inc (OTCMKTS:CIIX) Pulls Back in Red Hot Trend
February 4, 2017
OracleDispatch.com
Welcome to the Oracle Dispatch, a free online newspaper packed with exclusive content, news, articles and much more! Each day you’ll receive the latest business and industry news, financial analysis and much more. All this, and it’s free. Join the thousands of Oracle Dispatch users who are already with us! If you have any questions please visit contacts page.
EVEN MORE NEWS
NAKD Stock
Naked Brand Group Inc (NASDAQ:NAKD) Launches in Reaction to Product Launch
February 6, 2017
ERBB stock
American Green Inc (OTCMKTS:ERBB) Garners Attention with New App
February 6, 2017
NEWC stock
New Colombia Resources Inc (OTCMKTS:NEWC) Planting the Seeds
February 6, 2017
POPULAR CATEGORY
Investing
Opinion
Wall Street Daily
Sector News
© Copyright 2016 - Oracle Dispatch. All Rights Reserved
Sign up for our 100% FREE Oracle Dispatch Newsletter
SUBSCRIBE NOW!
